These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 7518761

  • 21. Antibiotic susceptibility of respiratory pathogens recently isolated in Italy: focus on cefditoren.
    Tempera G, Furneri PM, Carlone NA, Cocuzza C, Rigoli R, Musumeci R, Pilloni AP, Prenna M, Tufano MA, Tullio V, Vitali LA, Nicoletti G.
    J Chemother; 2010 Jun; 22(3):153-9. PubMed ID: 20566418
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Blandino G, Aleo G, Caccamo F, Nicolosi VM, Siracusa V, Speciale A.
    J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Clinical and bacteriological effects of cefetamet pivoxil against community-acquired respiratory tract infections. Part II].
    Shimada J, Ishihara R, Suzuki Y, Ishii Y, Nakazawa A, Deguchi K.
    Jpn J Antibiot; 1997 Sep; 50(9):756-67. PubMed ID: 9394236
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Antimicrobial activities of cefetamet against clinically isolated strains from community acquired respiratory tract infections. Part III].
    Matsumoto Y, Ishihara R, Suzuki Y, Nishinari C, Ishii Y, Nakane Y, Endo H.
    Jpn J Antibiot; 1999 Jun; 52(6):469-77. PubMed ID: 10481811
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Effect of inoculum size on the in-vitro susceptibility to beta-lactam antibiotics of Moraxella catarrhalis isolates of different beta-lactamase types.
    Yeo SF, Livermore DM.
    J Med Microbiol; 1994 Apr; 40(4):252-5. PubMed ID: 8151675
    [Abstract] [Full Text] [Related]

  • 30. Cefdinir: a review of its use in the management of mild-to-moderate bacterial infections.
    Perry CM, Scott LJ.
    Drugs; 2004 Apr; 64(13):1433-64. PubMed ID: 15212560
    [Abstract] [Full Text] [Related]

  • 31. [A comparative study of antibacterial activity of ceftibuten, ceftazidime, cefuroxime and ampicillin against clinical isolates].
    Ergova R, K'oleian E, Kharalambieva Ia, Mitov I, Docheva Iu.
    Vutr Boles; 2000 Apr; 32(1):13-7. PubMed ID: 11195191
    [Abstract] [Full Text] [Related]

  • 32. Survey of antimicrobial resistance to oral antibiotics in Italy.
    Cullmann W.
    Chemotherapy; 1993 Apr; 39(1):13-21. PubMed ID: 8444057
    [Abstract] [Full Text] [Related]

  • 33. Susceptibility of respiratory and urinary pathogens to ceftibuten and other comparative drugs: results of an Italian multicenter survey. The Italian Ceftibuten Study Group.
    Schito GC, Nicoletti G.
    J Chemother; 1994 Apr; 6(2):92-8. PubMed ID: 8077991
    [Abstract] [Full Text] [Related]

  • 34. [Microbiological aspects of antibiotics with immunomodulating action].
    Schito GC, Debbia EA, Nicoletti G, Blandino G, Cocuzza G, Dainelli B, Maida A.
    J Chemother; 1994 Aug; 6 Suppl 3():19-22. PubMed ID: 7861204
    [Abstract] [Full Text] [Related]

  • 35. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics].
    Susić E.
    Acta Med Croatica; 2004 Aug; 58(4):307-12. PubMed ID: 15700687
    [Abstract] [Full Text] [Related]

  • 36. Cefuroxime axetil. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
    Perry CM, Brogden RN.
    Drugs; 1996 Jul; 52(1):125-58. PubMed ID: 8799689
    [Abstract] [Full Text] [Related]

  • 37. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
    Wise R, Andrews JM, Ashby JP, Thornber D.
    J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
    [Abstract] [Full Text] [Related]

  • 38. [Effect of broad spectrum beta-lactamases on in vitro sensitivity of clinical isolates of Klebsiella pneumoniae to oral cephalosporins].
    Bedenić B, Singer S.
    Lijec Vjesn; 2000 Apr; 122(1-2):8-13. PubMed ID: 10916350
    [Abstract] [Full Text] [Related]

  • 39. Ceftibuten: minimal inhibitory concentrations, postantibiotic effect and beta-lactamase stability--a rationale for dosing programs.
    Neu HC.
    Pediatr Infect Dis J; 1995 Jul; 14(7 Suppl):S88-92. PubMed ID: 7567316
    [Abstract] [Full Text] [Related]

  • 40. Comparative in vitro activity of a pharmacokinetically enhanced oral formulation of amoxicillin/clavulanic acid (2000/125 mg twice daily) against 9172 respiratory isolates collected worldwide in 2000.
    Koeth LM, Jacobs MR, Good CE, Bajaksouzian S, Windau A, Jakielaszek C, Saunders KA.
    Int J Infect Dis; 2004 Nov; 8(6):362-73. PubMed ID: 15494258
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.